Adcock Ingram $1.2 Billion Buy By CFR Would Amass Huge Debt: Analyst
This article was originally published in PharmAsia News
Executive Summary
If Chile's CFR Pharmaceuticals were to acquire South Africa's Adcock Ingram Holdings over the objections of its largest stakeholder, it would be taking on a huge debt load, analysts said.